Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ChromaDex Inks Deal with Thorne Research for NiagenT - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

ChromaDex Inks Deal with Thorne Research for NiagenT

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

ChromaDex Corp., Irvine, CA, will enter a three-year marketing deal worth at least $3.5 million with Thorne Research Inc., Sandpoint, ID, for ChromaDex’s recently launched NiagenT, its novel, patented, branded nicotinamide riboside (NR) ingredient. Under the terms of the agreement, Thorne Research receives marketing rights for NiagenT for use in nutritional supplements exclusively for the direct to healthcare practitioner channel in the U.S. and Canada. ChromaDex will receive a royalty on sales of Thorne Research products that will contain NiagenT. In addition, Thorne Research will collaborate with ChromaDex on future human clinical trials of NiagenT.

According to the companies, NiagenT has the potential to become a part of the portfolio of B-vitamin ingredients included in products serving multi-billion dollar markets such as multivitamins, nutraceuticals, weight loss, energy drinks, sports nutrition, meal replacements, infant formula and food and beverage products.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics